Zobrazeno 1 - 10
of 110
pro vyhledávání: '"Hampton SL"'
Autor:
Allison M; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Davie RL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Mogg AJ; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Hampton SL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Emsley J; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Stocks MJ; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Mar 28; Vol. 15 (4), pp. 501-509. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Autor:
Clermont AC; KalVista Pharmaceuticals, Cambridge, United Kingdom., Murugesan N; KalVista Pharmaceuticals, Cambridge, United Kingdom., Edwards HJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Lee DK; KalVista Pharmaceuticals, Cambridge, United Kingdom., Bayliss NP; KalVista Pharmaceuticals, Cambridge, United Kingdom., Duckworth EJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Pethen SJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Hampton SL; KalVista Pharmaceuticals, Cambridge, United Kingdom., Gailani D; Hematology/Oncology Division, Vanderbilt University, Nashville, TN, United States., Feener EP; KalVista Pharmaceuticals, Cambridge, United Kingdom.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Dec 19; Vol. 14, pp. 1287487. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023).
Autor:
Davie RL; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Edwards HJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Evans DM; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Hodgson ST; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Stocks MJ; School of Pharmacy, University of Nottingham, University Park Campus, Nottingham NG7 2RD, U.K., Smith AJ; Sygnature Discovery, Biocity, Pennyfoot Street, Nottingham, NG1 1GR, U.K., Rushbrooke LJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Pethen SJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Roe MB; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Clark DE; Charles River Early Discovery, 6-9 Spire Green Centre, Harlow, Essex CM19 5TR, U.K., McEwan PA; Evotec, 114 Innovation Drive Milton Science Park, Abingdon, OX14 4RZ, U.K., Hampton SL; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Oct 27; Vol. 65 (20), pp. 13629-13644. Date of Electronic Publication: 2022 Oct 17.
Autor:
Duckworth EJ; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Murugesan N; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Li L; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Rushbrooke LJ; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Lee DK; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., De Donatis GM; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Maetzel A; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.; Institute for Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada., Yea CM; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Hampton SL; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Feener EP; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Sep; Vol. 52 (9), pp. 1059-1070. Date of Electronic Publication: 2022 Mar 20.
Autor:
Maetzel A; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass; Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada., Smith MD; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Duckworth EJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Hampton SL; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., De Donatis GM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Murugesan N; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Rushbrooke LJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Li L; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Francombe D; Simbec-Orion Ltd, Merthyr Tydfil, United Kingdom., Feener EP; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass. Electronic address: epf@kalvista.com., Yea CM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Jun; Vol. 149 (6), pp. 2034-2042. Date of Electronic Publication: 2022 Jan 24.
Autor:
Hampton, SL, Griffiths, CL
Publikováno v:
African Journal of Marine Science; Vol 29, No 1 (2007); 123-126
The European green crab Carcinus maenas has established considerable breeding populations in harbours and sheltered bays in the South-Western Cape, South Africa, but appears unable to flourish on the wave exposed coastline. This study compares the ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::ba1f4f95222781f921a4ee8cd419e95e
https://www.ajol.info/index.php/ajms/article/view/33453
https://www.ajol.info/index.php/ajms/article/view/33453
Autor:
Wisniewski, Petra1 (AUTHOR), Gangnus, Tanja1 (AUTHOR), Burckhardt, Bjoern B.1 (AUTHOR) burckhardt@uni-muenster.de
Publikováno v:
Journal of Translational Medicine. 4/26/2024, Vol. 22 Issue 1, p1-19. 19p.
Autor:
Magerl, Markus1,2 (AUTHOR) markus.magerl@charite.de, Sala‐Cunill, Anna3 (AUTHOR), Weber‐Chrysochoou, Christina4 (AUTHOR), Trainotti, Susanne5 (AUTHOR), Mormile, Ilaria6 (AUTHOR), Spadaro, Giuseppe6 (AUTHOR)
Publikováno v:
Clinical & Translational Allergy. Sep2023, Vol. 13 Issue 9, p1-12. 12p.
Autor:
Hampton SL; Department of Rheumatology, Aberdeen Royal Infirmary, Aberdeen, UK., Youssef H
Publikováno v:
BMJ case reports [BMJ Case Rep] 2013 Jan 25; Vol. 2013. Date of Electronic Publication: 2013 Jan 25.
Autor:
Hampton SL; Vantia Ltd., Southampton, UK. Sally.Hampton@Vantia.com, Kinnaird AI
Publikováno v:
Cell biology and toxicology [Cell Biol Toxicol] 2010 Feb; Vol. 26 (1), pp. 43-55. Date of Electronic Publication: 2009 Nov 11.